Fig. 3From: Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patientsComparisons of glycemic and pleiotropic effects between SGLT2 inhibitors and DPP4 inhibitors in patients with different eGFR levels. a Baseline eGFR < 60 ml/min/1.73m2. b Baseline eGFR ≥ 60 ml/min/1.73m2Back to article page